Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Venous Ethanol for Ventricular Tachycardia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating venous ethanol for treating ventricular tachycardia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venous Ethanol (ethanol)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Ventricular Tachycardia, Ischemic Cardiomyopathy | Phase 2 | Status: RECRUITING